We may conclude that the synergy of cancer cell growth suppression is apparent, from the impact of the potency of the combination of alectinib and SHP099 from the beginning of the ALK signalling pathway through multiple steps that encompass the regulation of the cell cycle and apoptosis. Here, ALK is linked to cancer.